DexCom
DXCM
910 hedge funds and large institutions have $24.5B invested in DexCom in 2025 Q3 according to their latest regulatory filings, with 111 funds opening new positions, 337 increasing their positions, 344 reducing their positions, and 132 closing their positions.
0.34% less ownership
Funds ownership: 93.37% → 93.03% (-0.34%)
2% less repeat investments, than reductions
Existing positions increased: 337 | Existing positions reduced: 344
3% less funds holding
Funds holding: 939 → 910 (-29)
11% less call options, than puts
Call options by funds: $480M | Put options by funds: $539M
16% less first-time investments, than exits
New positions opened: 111 | Existing positions closed: 132
23% less capital invested
Capital invested by funds: $31.9B → $24.5B (-$7.41B)
25% less funds holding in top 10
Funds holding in top 10: 8 → 6 (-2)
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$428M |
| 2 |
Millennium Management
New York
|
+$252M |
| 3 |
Holocene Advisors
New York
|
+$193M |
| 4 |
CIBC Private Wealth Group
Atlanta,
Georgia
|
+$182M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$177M |
Top Sellers
| 1 |
Sands Capital Management
Arlington,
Virginia
|
-$397M |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
-$240M |
| 3 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$220M |
| 4 |
Axa
Paris,
France
|
-$189M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$167M |
DXCM Hedge Fund Activity: Q3 2025 in Review
910 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in DexCom (DXCM) for Q3 2025, worth a combined $24.5B — down 23% from $31.9B a quarter earlier.
Sellers outnumbered buyers: 132 funds closed out of DXCM and 111 opened new positions — a net loss of 21 holders — while 344 trimmed existing stakes and 337 added.
The largest buyer was Citadel Advisors, adding an estimated $428M. The largest seller was Sands Capital Management, cutting an estimated $397M.
- 910 institutional investors held DexCom (DXCM) as of Q3 2025, down from 939 in Q2 2025.
- Funds reported $24.5B of DexCom stock for Q3 2025, down 23% quarter-over-quarter.
- 111 funds opened new DexCom positions in Q3 2025 and 132 closed out, a net change of -21 holders.
- The largest DexCom buyer in Q3 2025 was Citadel Advisors, an estimated $428M added.
- The largest DexCom seller in Q3 2025 was Sands Capital Management, an estimated $397M sold.
Based on aggregated 13F filings for Q3 2025.